Trapp Todd A's Form 4 filing
Abiomed IncABMD · filed Nov 3, 2022
- Accession no.
- 0001415889-22-011061
- Filed
- Nov 3, 2022
- Trade date
- Nov 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $378.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trapp Todd ACIK 0001638242 | Officer (VICE PRESIDENT, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −263 | $377.82F2 | −$99,366.66 | 16,664 | Direct | |
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −479 | $378.64F3 | −$181,368.56 | 16,185 | Direct | |
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −191 | $379.35F4 | −$72,455.85 | 15,994 | Direct | |
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −67 | $380.20F5 | −$25,473.4 | 15,927 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the sale price of the transactions on the reported date at $377.8200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the sale price of the transactions on the reported date at $378.6378. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the sale price of the transactions on the reported date at $379.3497. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the sale price of the transactions on the reported date at $380.1973. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.